Australian Other Utilities Stock News

AI restructure, e2open integration and earnings set the tone WiseTech Global (ASX:WTC) has been in focus after its half year 2026 results, an AI led restructure involving up to 2,000 job cuts, and earlier than planned cost synergies from the e2open acquisition. On the same day, the company also reported a fully franked interim dividend, reaffirmed its fiscal 2026 revenue guidance in the US$1.39b to US$1.44b range, and outlined how these moves fit into a broader shift toward an AI led...

In late February 2026, Domino’s Pizza Enterprises reported half-year results showing A$1,101.8 million in sales and A$40.92 million in net income, declared a A$0.25 per share cash dividend with an ex-date of 3 March 2026, and announced a new independent non-executive director, Drew O’Malley, effective 2 April 2026. The combination of a return to profitability, a higher cash distribution, and the addition of an experienced quick-service restaurant executive signals management’s focus on...

Flight Centre Travel Group has reported past half-year results showing A$1,408.48 million in sales, stable net income of A$60.46 million, declared a A$0.12 per share dividend, and completed a buyback of 9,800,000 shares for A$126 million under its program announced in April 2025. Together, the earnings, dividend and completed buyback highlight how Flight Centre Travel Group is using capital returns alongside steady profitability to shape shareholder outcomes. We will now examine how the new...

ARB (ASX:ARB) has put fresh numbers on the table, pairing a half year earnings update showing sales and net income below the prior period with a fully franked A$0.34 dividend declaration. See our latest analysis for ARB. At a share price of A$23.91, ARB has seen a 1 day share price return of 1.06% after the earnings and dividend update. However, the 90 day share price return of 25.65% and 1 year total shareholder return of 27.41% indicate that momentum has been fading over both shorter and...

Why Aussie Broadband’s latest results caught the market’s eye Aussie Broadband (ASX:ABB) has just posted half year earnings alongside confirming an ordinary fully franked dividend. This combination often pulls investor focus because it directly links recent performance with upcoming cash returns. See our latest analysis for Aussie Broadband. The latest half year release, dividend confirmation and recent board change have arrived after a mixed stretch for the stock, with a 14.3% 1 month share...

New operating structure reshapes Lottery’s business focus Lottery (ASX:TLC) has rolled out a new operating structure built around three core units: Lotteries, Digital, and Keno, alongside executive leadership changes intended to support faster decision-making and a clearer business focus. See our latest analysis for Lottery. Against this backdrop, Lottery’s recent 30 day share price return of 4.83% and year to date share price return of 4.42% point to gradually improving momentum, while a 1...

In early March 2026, Life360 reported fourth-quarter 2025 revenue of US$145.98 million and full-year revenue of US$489.48 million, delivering its first full-year net income of US$150.83 million after a prior-year net loss. The company coupled this profitability milestone with 2026 revenue guidance of US$640 million to US$680 million and an AI-first, subscription- and advertising-focused roadmap, highlighting how new offerings like Pet GPS and the Nativo acquisition fit into its broader...

Why Chris Mackay’s insider buying matters for MFF Capital Investments (ASX:MFF) Director Chris Mackay’s recent on-market purchase of additional MFF Capital Investments (ASX:MFF) shares puts fresh attention on insider activity, with many investors using such moves as a cue to reassess valuation and alignment. See our latest analysis for MFF Capital Investments. MFF’s A$4.72 share price has seen a modest 7 day share price return decline of 3.28% and a year to date share price return decline of...

Carmel Monaghan’s recent purchase of 2,200 shares in Regis Healthcare (ASX:REG) has drawn investor attention, as her first recorded holding directly ties boardroom incentives to shareholder outcomes and signals increased governance alignment. See our latest analysis for Regis Healthcare. Regis Healthcare’s A$6.78 share price sits against a mixed near term picture, with a 7 day share price return of 2.45% decline and a 90 day share price return of 11.83% decline, yet the 1 year and 5 year...

Austal (ASX:ASB) is back in focus after releasing half year 2025 results along with fresh fiscal 2026 EBIT guidance of about A$110 million, giving investors new detail on both recent performance and management expectations. See our latest analysis for Austal. The latest guidance and half year results land after a weak patch for the shares, with a 30 day share price return of an 18.42% decline and a 90 day share price return of a 19.17% decline, even as the 1 year total shareholder return sits...

Half year earnings drop and dividend decision come into focus Generation Development Group (ASX:GDG) has put fresh numbers on the table, with half year net income of A$6.85 million compared with A$78.88 million a year earlier, alongside an ordinary fully franked dividend of A$0.01 per share. See our latest analysis for Generation Development Group. At a share price of A$4.41, Generation Development Group has seen a 2.8% 1 day share price return, but a 30 day share price return of 11.45%...

Resolute Mining Limited recently released its full-year 2025 results, reporting net income of US$110.4 million versus a net loss of US$28.3 million a year earlier, alongside a conference presentation at the 35th BMO Global Metals, Mining & Critical Minerals Conference in Hollywood, Florida. The swing from a basic loss per share of US$0.0133 to basic earnings per share of US$0.0518 highlights a sharp turnaround in profitability that may reflect meaningful operational and cost improvements...

Ramsay Health Care Limited recently reported half-year 2025 results showing revenue of A$9,382.8 million and net profit after tax of A$160.7 million, and declared a fully franked interim dividend of A$0.425 per share for the six months ended December 31, 2025, payable on March 26, 2026. This marks a move back into profitability from a loss a year earlier, highlighting the impact of cost control efforts and portfolio optimisation on Ramsay’s earnings profile. We’ll now examine how Ramsay’s...

Dateline Resources Limited has commenced exploration at its newly acquired Music Valley Heavy Rare Earth Project in Riverside County, California, launching a high-resolution helicopter-borne magnetic and radiometric survey alongside detailed geological mapping and rock chip sampling. By engaging rare earth specialist Tony Mariano Jr and structural geologist Dr Russell Mason, the company is seeking to build a refined geological model that could pinpoint priority zones for more focused work...

The NSW Government’s backing of AGL Energy (ASX:AGL) Hunter Energy Hub through the new Investment Delivery Authority puts fresh attention on how this former coal site could shape the company’s long term energy transition plans. See our latest analysis for AGL Energy. At a share price of A$9.65, AGL Energy has seen short term share price softness, with a 1 day return of 1.73% and 7 day return of 2.43%. Its 30 day share price return of 6.87% and 3 year total shareholder return of 64.97% point...

Karoon Energy (ASX:KAR) has just packed several updates into a short window, reporting its full year 2025 results, issuing 2026 production guidance, and declaring a cash dividend of A$0.031 per share. See our latest analysis for Karoon Energy. The recent full year results, 2026 production guidance and new dividend appear to have caught the market’s attention, with a 7 day share price return of 17.48% and a 1 year total shareholder return of 23.16% at a last close of A$1.815. However, the 3...

Alkane Resources (ASX:ALK) is back in focus after director and major shareholder Bradford Mills sold 25,000,000 shares for A$42,000,000, shortly after the company reported high grade gold and antimony exploration results. See our latest analysis for Alkane Resources. Despite the recent A$1.6 share price and short term weakness, with a 1 day share price return of 3.03% decline and a 7 day share price return of 8.57% decline, Alkane Resources still shows strong momentum when you zoom out. The...

If you are wondering whether Westpac Banking's current share price still offers value, this article will walk through what the numbers are really saying about the stock. Westpac shares recently closed at A$41.00, with returns of a 3.6% decline over 7 days, 2.8% over 30 days, 5.3% year to date, 40.1% over 1 year and 119.3% over 5 years, which has many investors reassessing both its growth potential and risk profile. This article is part of our evergreen coverage of Westpac. It looks beyond...

Endeavour Group (ASX:EDV) has come into focus after releasing its half year FY26 results, which showed lower net profit, a reduced interim dividend and contrasting trends between its retail and hotels operations. See our latest analysis for Endeavour Group. At a share price of A$3.93, Endeavour Group has seen a 7.4% 1 month share price return and a 6.8% year to date share price return. However, its 1 year total shareholder return of 5.3% and 3 year total shareholder return of 35.7% underline...

A recent sell call on Xero (ASX:XRO) has put the stock in focus, with the analyst pointing to sector rotation away from higher P/E technology names and the potential for further downside until confidence improves. See our latest analysis for Xero. Despite the recent sell call, Xero’s share price has shown a short term rebound, with a 1 day share price return of 4.46% and a 30 day share price return of 8.43%. However, its year to date share price return of 21.93% and 1 year total shareholder...

Earnings shock puts 4DMedical’s losses in focus 4DMedical (ASX:4DX) reported half year earnings to 31 December 2025 that kept sales near A$2.85 million, while net loss widened to A$154.14 million and basic loss per share reached A$0.311. With revenue relatively unchanged from A$2.9 million a year earlier, the size of the current loss compared with A$11.28 million previously is likely to have investors focusing closely on cash use and expense trends. See our latest analysis for...

Pro Medicus recently presented at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, while co-founders Sam Hupert and Anthony Hall purchased A$3.4 million of shares on market and shareholders prepare to receive an interim dividend on March 20. Together, the insider buying and imminent cash payout highlight management’s confidence in the business and may be refocusing investors on Pro Medicus’s fundamentals despite recent technical selling pressure. With insider...

WiseTech Global Limited recently reported past half-year results to December 31, 2025, with sales rising to US$672,000,000 while net income eased to US$68,100,000, and reaffirmed its fiscal 2026 revenue guidance range of US$1.39 billion to US$1.44 billion. The company also declared an estimated fully franked ordinary dividend of US$0.068 per share for the period, signalling confidence in its cash generation despite lower earnings per share. We’ll now examine how WiseTech’s reaffirmed fiscal...

Telix Pharmaceuticals (ASX:TLX) has drawn fresh attention after announcing a collaboration with University Hospital Essen to apply artificial intelligence to the large PROMISE-PET registry for PSMA-PET imaging in prostate cancer. See our latest analysis for Telix Pharmaceuticals. The new AI collaboration comes after a period of mixed performance, with Telix’s 1-day share price return of 6.54% and 7-day return of 7.50% contrasting with a 90-day share price decline of 27.41% and a 1-year total...